| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |